Retrospective review of lymphocyte changes when switching between fumarates in patients with multiple sclerosis
Our study demonstrated that patients switched to DRF had a significantly lower ALC at follow-up and were more likely to have lymphopenia compared to patients switched to MMF.
Institutions
- Vanderbilt Health (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Multiple Sclerosis and Related Disorders
- Published
- 2026-01-02
- DOI
- https://doi.org/10.1016/j.msard.2026.106968
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Georgia Clinical and Translational Science Alliance
- National Institutes of Health
- National Center for Advancing Translational Sciences